Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease
Mikio Shiba(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Hideshi Okada(Gifu University), Hisao Ogawa(Kumamoto University Hospital), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshihiko Ikeda(National Cerebral and Cardiovascular Center), Yasuo Sugano(keiyu Hospital), Toshiyuki Nagai(Hokkaido University), Satoshi Yasuda(Tohoku University)
Cited by 27
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755